437864447	437864447	CD	B-NP	O
|	|	NN	I-NP	O
TH	TH	NN	I-NP	O
|	|	NN	I-NP	O
27718934	27718934	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
147806	147806	CD	B-NP	O
|	|	CC	I-NP	O
11/8/2001	11/8/2001	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
NQWMI	NQWMI	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/28/2001	9/28/2001	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/9/2001	5/9/2001	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
EHLI	EHLI	NNP	B-NP	O
,	,	,	O	O
MONTY	MONTY	NNP	B-NP	O
896-85-50-6	896-85-50-6	CD	I-NP	O
Gene	Gene	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
1/12/01	1/12/01	CD	B-NP	O
AT	AT	NN	I-NP	O
02	02	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
HELSEY	HELSEY	NNP	B-NP	O
,	,	,	O	O
MANUEL	MANUEL	NNP	B-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ECASA	ECASA	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
GLIPIZIDE	GLIPIZIDE	NN	I-NP	O
10	10	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QAM	QAM	NN	I-NP	O
HCTZ	HCTZ	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
50	50	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
NITROGLYCERIN	NITROGLYCERIN	NNP	I-NP	O
1/150	1/150	CD	I-NP	O
-LRB-	-LRB-	HYPH	O	B-DNA
0.4	0.4	CD	B-NP	I-DNA
MG	MG	NN	I-NP	I-DNA
-RRB-	-RRB-	HYPH	B-NP	I-DNA
1	1	CD	I-NP	I-DNA
TAB	TAB	NN	I-NP	I-DNA
SL	SL	NN	I-NP	I-DNA
q5min	q5min	NN	I-NP	I-DNA
x	x	SYM	B-NP	I-DNA
3	3	CD	I-NP	I-DNA
PRN	PRN	NN	I-NP	I-DNA
chest	chest	NN	I-NP	I-DNA
pain	pain	NN	I-NP	I-DNA
ZOCOR	ZOCOR	NN	I-NP	I-DNA
-LRB-	-LRB-	NN	I-NP	I-DNA
SIMVASTATIN	SIMVASTATIN	NN	I-NP	I-DNA
-RRB-	-RRB-	NN	I-NP	I-DNA
20	20	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
QHS	QHS	NNP	I-NP	I-DNA
Food/Drug	Food/Drug	NNP	I-NP	I-DNA
Interaction	Interaction	NNP	I-NP	I-DNA
Instruction	Instruction	NNP	I-NP	I-DNA
Avoid	Avoid	NNP	I-NP	I-DNA
grapefruit	grapefruit	NN	I-NP	I-DNA
unless	unless	IN	B-SBAR	I-DNA
MD	MD	NN	B-NP	I-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

PLAVIX	PLAVIX	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
CLOPIDOGREL	CLOPIDOGREL	NN	I-NP	O
-RRB-	-RRB-	HYPH	O	O
75	75	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
TOPROL	TOPROL	NNP	I-NP	O
XL	XL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SUST	SUST	NNP	I-NP	O
.	.	.	O	O

REL	REL	NN	B-NP	B-protein
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O

100	100	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

IMDUR	IMDUR	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ISOSORBIDE	ISOSORBIDE	NNP	I-NP	O
MONONIT	MONONIT	NNP	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	NN	B-NP	O
SR	SR	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
30	30	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-PP	O
food	food	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
LISINOPRIL	LISINOPRIL	NN	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
DIET	DIET	NNP	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
RETURN	RETURN	NNP	I-NP	O
TO	TO	NNP	I-NP	O
WORK	WORK	NNP	I-NP	O
:	:	:	O	O
Not	Not	NNP	B-NP	O
Applicable	Applicable	NNP	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Yearick	Yearick	NNP	I-NP	O
1	1	CD	I-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Faraone	Faraone	NNP	I-NP	O
3	3	CD	I-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Gualtieri	Gualtieri	NNP	I-NP	O
TBA	TBA	NNP	I-NP	O
,	,	,	O	O
No	No	NNP	B-NP	O
Known	Known	NNP	I-NP	O
Allergies	Allergies	NNP	I-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
MI	MI	NN	B-NP	O
,	,	,	O	O
peripheral	peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
h/o	h/o	NN	B-NP	O
CVA	CVA	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
NQWMI	NQWMI	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
peripheral	peripheral	JJ	I-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
peripheral	peripheral	JJ	I-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
critical	critical	JJ	I-NP	O
aortic	aortic	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
aortic	aortic	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
CAD	CAD	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
chronic	chronic	JJ	I-NP	O
leg	leg	NN	I-NP	O
ulcers	ulcer	NNS	I-NP	O
-LRB-	-LRB-	VBP	B-VP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	B-protein
ulcer	ulcer	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
diabetes	diabete	VBZ	B-VP	O
-LRB-	-LRB-	NN	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Caridac	Caridac	NNP	I-NP	O
cathetherization	cathetherization	NN	I-NP	O
,	,	,	O	O
ETT	ETT	NNP	B-NP	O
MIBI	MIBI	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
63	63	CD	B-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
male	male	JJ	I-NP	O
h/o	h/o	NN	I-NP	O
DM	DM	NN	I-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
AS	AS	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	O	O
0.9	0.9	CD	B-NP	O
cm2	cm2	NN	I-NP	O
-RRB-	-RRB-	SYM	B-NP	O
MI	MI	NN	I-NP	O
x	x	SYM	B-NP	O
2	2	CD	B-NP	O
,	,	,	O	O
PVD	PVD	NN	B-NP	O
s/p	s/p	NN	I-NP	O
B	B	NN	I-NP	O
fem/pop	fem/pop	NN	I-NP	O
with	with	IN	B-PP	O
bi	bi	NN	B-NP	O
revisions	revision	NNS	I-NP	O
p/w	p/w	NN	I-NP	O
2	2	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
SSCP	SSCP	NN	B-NP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
.	.	.	O	O

Had	Have	VBD	B-VP	O
2	2	CD	B-NP	O
MI	MI	NN	I-NP	O
's	'	VBZ	B-VP	O
this	this	DT	B-NP	O
pas	pas	NN	I-NP	O
t	t	NN	I-NP	O
year	year	NN	I-NP	O
.	.	.	O	O

First	First	RB	B-ADVP	O
in	in	IN	B-PP	O
3/23	3/23	CD	B-NP	O
peri-op	peri-op	NN	I-NP	O
during	during	IN	B-PP	O
a	a	DT	B-NP	O
fem-pop	fem-pop	JJ	I-NP	O
bypass	bypass	NN	I-NP	O
NSTEMI	NSTEMI	NN	I-NP	O
medically	medically	RB	B-NP	O
manage	manage	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
second	second	JJ	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
4/17	4/17	CD	B-NP	O
during	during	IN	B-PP	O
skin	skin	NN	B-NP	O
graft	graft	NN	I-NP	O
surgery	surgery	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
time	time	NN	I-NP	O
he	he	PRP	B-NP	O
went	go	VBD	B-VP	O
to	to	TO	B-PP	O
cath	cath	NN	B-NP	O
70	70	CD	B-NP	O
%	%	NN	I-NP	O
ramus	ramus	NN	I-NP	O
,	,	,	O	O
70	70	CD	B-NP	O
%	%	NN	I-NP	O
RCA	RCA	NN	I-NP	O
lesions	lesion	NNS	I-NP	O
X	X	SYM	B-VP	O
2	2	CD	B-NP	O
.	.	.	O	O

all	all	DT	B-NP	O
three	three	CD	I-NP	O
lesions	lesion	NNS	I-NP	O
were	be	VBD	B-VP	O
PTCA/stented	PTCA/stente	VBN	I-VP	O
.	.	.	O	O

EF	EF	NN	B-NP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
30-35	30-35	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Since	Since	IN	B-SBAR	O
his	his	PRP$	B-NP	O
second	second	JJ	I-NP	O
MI	MI	NN	I-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
2-3	2-3	CD	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
CP	CP	NN	B-NP	B-DNA
per	per	IN	B-PP	O
week	week	NN	B-NP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
his	his	PRP$	B-NP	O
pain	pain	NN	I-NP	O
5/10	5/10	CD	I-NP	O
lasting	last	VBG	B-VP	O
for	for	IN	B-PP	O
5-10	5-10	CD	B-NP	O
min	min	NN	I-NP	O
.	.	.	O	O

at	at	IN	B-PP	O
a	a	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

Had	Have	VBD	B-VP	O
7-10	7-10	CD	B-NP	O
episodes	episode	NNS	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
days	day	NNS	I-NP	O
PTA	PTA	NN	I-NP	B-protein
.	.	.	O	O

Night	Night	NN	B-NP	B-protein
PTA	PTA	NN	I-NP	I-protein
thought	think	VBD	B-VP	O
episodes	episode	NNS	B-NP	O
would	would	MD	B-VP	O
resolve	resolve	VB	I-VP	O
.	.	.	O	O

Awoke	Awoke	NN	B-NP	O
morning	morning	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
with	with	IN	B-PP	O
SSCP	SSCP	NN	B-NP	O
,	,	,	O	O
dizziness	dizziness	NN	B-NP	O
,	,	,	O	O
palpitaions	palpitaion	NNS	B-NP	O
,	,	,	O	O
diaphoresis	diaphoresis	NN	B-NP	O
Sxs	Sx	NNS	I-NP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
previous	previous	JJ	B-NP	O
MI	MI	NN	I-NP	O
's	's	POS	B-NP	O
.	.	.	O	O

Called	Call	VBN	B-NP	O
EMS	EMS	NNS	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
to	to	TO	B-PP	O
ED	ED	NN	B-NP	O
.	.	.	O	O

Peak	Peak	JJ	B-NP	O
troponin	troponin	NN	I-NP	O
1.47	1.47	CD	I-NP	O
.	.	.	O	O

EKG	EKG	NNP	B-NP	O
-	-	HYPH	I-NP	O
TW	TW	NNP	I-NP	O
flattening	flattening	NN	I-NP	O
II	II	CD	I-NP	O
,	,	,	I-NP	O
II	II	CD	I-NP	O
,	,	,	I-NP	O
F	F	NN	I-NP	O
and	and	CC	I-NP	O
I	I	NN	I-NP	O
,	,	,	O	O
AVL	AVL	NN	B-NP	O
.	.	.	O	O

CV	CV	NN	B-NP	O
-	-	HYPH	O	O
Anticoagulated	Anticoagulate	VBN	B-VP	O
with	with	IN	B-PP	O
heparin	heparin	NN	B-NP	O
,	,	,	O	O
plavix	plavix	NN	B-NP	O
,	,	,	O	O
integrillin	integrillin	NN	B-NP	B-protein
.	.	.	O	O

Echo	Echo	NN	B-NP	O
:	:	:	O	O
mild	mild	JJ	B-NP	O
concentric	concentric	JJ	I-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
,	,	,	O	O
EF	EF	NN	B-NP	O
55	55	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
severe	severe	JJ	B-NP	O
aortic	aortic	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
with	with	IN	B-PP	O
valve	valve	JJ	B-NP	O
area	area	NN	I-NP	O
of	of	IN	B-PP	O
0.9	0.9	CD	B-NP	O
cm2	cm2	NN	I-NP	O
,	,	,	O	O
peak	peak	NN	B-NP	O
and	and	CC	O	O
mean	mean	JJ	B-NP	O
gradient	gradient	NN	I-NP	O
56/36	56/36	CD	I-NP	O
.	.	.	O	O

Adenosine	Adenosine	NN	B-NP	O
MIBI	MIBI	NN	I-NP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
is	be	VBZ	B-VP	O
chemia	chemia	NN	B-NP	O
.	.	.	O	O

Taken	Take	VBN	B-VP	O
to	to	TO	B-PP	O
cath	cath	NN	B-NP	O
:	:	:	O	O
LCx	LCx	NN	B-NP	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
ramus	ramus	NN	B-NP	O
35	35	CD	I-NP	O
%	%	NN	I-NP	O
marginal	marginal	JJ	I-NP	O
100	100	CD	I-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
RCA	RCA	NN	B-NP	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
90	90	CD	B-NP	O
%	%	NN	I-NP	O
mid	mid	NN	I-NP	O
stented	stente	VBD	B-VP	O
to	to	TO	B-PP	O
0	0	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Aortic	Aortic	JJ	B-NP	B-protein
gradient	gradient	NN	I-NP	I-protein
24.7	24.7	CD	I-NP	I-protein
,	,	,	O	O
AV	AV	NN	B-NP	O
valve	valve	NN	I-NP	O
area	area	NN	I-NP	O
0.87	0.87	CD	I-NP	O
.	.	.	O	O

Did	Do	VBD	B-VP	O
well	well	RB	B-NP	O
post	post	JJ	I-NP	O
cath	cath	NN	I-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
d/c	d/c	NN	B-NP	O
'd	'd	MD	B-VP	O
to	to	TO	I-VP	O
outpatient	outpatient	VB	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
needs	need	NNS	I-NP	O
continuing	continue	VBG	B-VP	O
visiting	visit	VBG	I-VP	O
nuse	nuse	NN	B-NP	O
care	care	NN	I-NP	O
for	for	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
monitoring	monitoring	NN	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
,	,	,	O	O
hear	hear	NN	B-NP	O
rate	rate	NN	I-NP	O
.	.	.	O	O

Needs	Need	VBZ	B-VP	O
physcial	physcial	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

Dressing	Dress	VBG	B-NP	O
changes	change	NNS	I-NP	O
everyday	everyday	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
few	few	JJ	I-NP	O
days	day	NNS	I-NP	O
post	post	VBP	B-VP	O
discharge	discharge	NN	B-NP	O
then	then	RB	B-ADVP	O
evaluate	evaluate	VB	B-VP	O
with	with	IN	B-PP	O
patient	patient	NN	B-NP	O
's	's	POS	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
takers	taker	NNS	I-NP	O
Drs.	Drs.	NNP	B-NP	O
Kreinhagen	Kreinhagen	NNP	I-NP	O
and	and	CC	O	O
Dr.	Dr.	NNP	B-NP	O
Whatcott	Whatcott	NNP	I-NP	O
.	.	.	O	O

Dressing	Dress	VBG	B-NP	O
changes	change	NNS	I-NP	O
will	will	MD	B-VP	O
consist	consist	VB	I-VP	O
of	of	IN	B-PP	O
cleaning	cleaning	NN	B-NP	O
with	with	IN	B-PP	O
saline	saline	NN	B-NP	O
,	,	,	O	O
xerofrom	xerofrom	IN	B-ADJP	O
over	over	IN	B-PP	O
wond	wond	NN	B-NP	O
,	,	,	O	O
wrapped	wrap	VBN	B-VP	O
in	in	IN	B-PP	O
dry	dry	JJ	B-NP	O
dressing	dressing	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
BAIRAM	BAIRAM	NNP	B-NP	O
,	,	,	O	O
SCOTTY	SCOTTY	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NZ47	NZ47	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
1/12/01	1/12/01	CD	I-NP	O
@	@	NN	I-NP	O
02	02	CD	I-NP	O
:	:	:	O	O
27	27	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

